Transmissible Spongiform Encephalopathy Statement

Preferred Label : Transmissible Spongiform Encephalopathy Statement;

NCIt related terms : TSE Stmt; TSE Statement;

NCIt definition : A declaration that proper measures have been taken to ensure that the risk for spreading transmissible spongiform encephalopathy (TSE) through the use of the Investigational Product (IP) has been minimized, which may include being manufactured with materials of a non-animal origin.;

Alternative definition : CareLex: A written confirmation that the investigational product (IP) has been either manufactured of materials of non-animal origin or, if using materials of animal origin, that all measures have been taken to minimize the risk of spreading transmissible spongiform encephalopathy (TSE) via medicinal products. May be included in Clinical Trial Applications.;

Détails

Origin ID

C115595;

UMLS CUI

C3897345;

Automatic exact mappings (from CISMeF team)
- Human prion disease [ORDO Disease]
- Transmissible spongiform encephalopathy [LOINC component]
- prion diseases [MeSH Descriptor]
Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- CareLex eTMF Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients